| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
5 companies
Leslie W. Kreis last filed a Form 4 in June 2025, as Director, 10% Owner at INAB. The filings on record cover 5 companies. From June 2020 to June 2025, the filings on record show 11 open-market purchases and 11 sales. Leslie W. Kreis's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Leslie W. Kreis a below-average insider score of 45/100, based on 28 past trades. Over a 12-month horizon, 32.1% of those trades were profitable, with an average 12-month return of -16.7%.
At the last filing, the largest reported position was 570,724 shares of INAB. Net of sales, the INAB filings show accumulation of 1,974,899 shares.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | INAB In8bio, Inc. | Director, 10% Owner | Buy | 50,000 | $1.93 | $96,500.00 | +9.9% | -20.2% | -42.4% | |
| Aug 16, 2022 | INAB In8bio, Inc. | Director, 10% Owner | Buy | 1,773,684 | $1.90 | $3,369,999.60 | -143.8% | -19.6% | -37.0% |